Literature DB >> 8329463

Use of mass spectrometric molecular weight information to identify proteins in sequence databases.

M Mann1, P Højrup, P Roepstorff.   

Abstract

During the last decade new ionization techniques have made it possible to measure the molecular weight of many intact proteins by mass spectrometry, and they have made it much easier to obtain a mass spectrometric peptide map of a protein. At the same time advances in protein and DNA sequencing technology are resulting in an exponential increase in the number of sequences deposited in databases. Here we investigate the possibility to use mass spectrometric data to identify proteins in databases. Searching a database by total molecular weight is found to be an easy and sometimes sufficient approach. For more specificity and for error tolerance in both the mass spectrometric data and the database information we search by partial mass spectrometric peptide map of the protein. In general, just four to six proteolytic peptides measured with a mass accuracy between 0.1 and 0.01% allow a useful search of databases such as the Protein Identification Resource (PIR). As the size of DNA and protein sequence databases grows, protein identification by partial mass spectrometric peptide maps should become increasingly powerful and may become a general method to identify and characterize proteins.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8329463     DOI: 10.1002/bms.1200220605

Source DB:  PubMed          Journal:  Biol Mass Spectrom        ISSN: 1052-9306


  102 in total

1.  Use of two-dimensional gel electrophoresis to measure changes in synovial fluid proteins from patients with rheumatoid arthritis treated with antibody to CD4.

Authors:  M A Smith; S K Bains; J C Betts; E H Choy; E D Zanders
Journal:  Clin Diagn Lab Immunol       Date:  2001-01

2.  Protein identification by in-gel digestion, high-performance liquid chromatography, and mass spectrometry: peptide analysis by complementary ionization techniques.

Authors:  K F Medzihradszky; H Leffler; M A Baldwin; A L Burlingame
Journal:  J Am Soc Mass Spectrom       Date:  2001-02       Impact factor: 3.109

3.  Angiostatin binds ATP synthase on the surface of human endothelial cells.

Authors:  T L Moser; M S Stack; I Asplin; J J Enghild; P Højrup; L Everitt; S Hubchak; H W Schnaper; S V Pizzo
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

4.  Functional analysis of the human CDC5L complex and identification of its components by mass spectrometry.

Authors:  P Ajuh; B Kuster; K Panov; J C Zomerdijk; M Mann; A I Lamond
Journal:  EMBO J       Date:  2000-12-01       Impact factor: 11.598

5.  Mass measurement errors caused by 'local" frequency perturbations in FTICR mass spectrometry.

Authors:  Christophe Masselon; Aleksey V Tolmachev; Gordon A Anderson; Richard Harkewicz; Richard D Smith
Journal:  J Am Soc Mass Spectrom       Date:  2002-01       Impact factor: 3.109

6.  Scoring methods in MALDI peptide mass fingerprinting: ChemScore, and the ChemApplex program.

Authors:  Kenneth C Parker
Journal:  J Am Soc Mass Spectrom       Date:  2002-01       Impact factor: 3.109

7.  Frequency shifts due to the interference of resolved peaks in magnitude-mode Fourier-transform ion cyclotron resonance mass spectra.

Authors:  Aleksey V Tolmachev; Christophe D Masselon; Gordon A Anderson; Harold R Udseth; Richard D Smith
Journal:  J Am Soc Mass Spectrom       Date:  2002-04       Impact factor: 3.109

Review 8.  Molecular biologist's guide to proteomics.

Authors:  Paul R Graves; Timothy A J Haystead
Journal:  Microbiol Mol Biol Rev       Date:  2002-03       Impact factor: 11.056

9.  Visualization and analysis of molecular scanner peptide mass spectra.

Authors:  Markus Müller; Robin Gras; Ron D Appel; Willy V Bienvenut; Denis F Hochstrasser
Journal:  J Am Soc Mass Spectrom       Date:  2002-03       Impact factor: 3.109

Review 10.  Mass spectrometry innovations in drug discovery and development.

Authors:  D I Papac; Z Shahrokh
Journal:  Pharm Res       Date:  2001-02       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.